Artoss Hits Record Sales of NanoBone Bone Graft

Artoss NanoBone Bone Graft Substitute

Artoss has achieved record sales of NanoBone Bone Graft products in 3Q20.

NanoBone Bone Graft is FDA 510(k) cleared for use as a standalone graft, including in spinal fusion, for its ability to create an osteogenic environment that replicates the architecture and chemistry found in natural bone. The products have been used in Europe and the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us